Views & Analysis | Perspectives on pharma industry issues

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Market Access

Sponsored

The pre-commercial case for connecting data before acquiring...

For EBPs, launch requires a data strategy that starts with agreement on the KPIs, and those depend on the therapeutic areas.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Patients

pharmaphorum podcast Episode 281 - Cecilia Caetano, Bayer

Sponsored

Menopause is an urgent global health issue: Bayer’s Cecilia ...

Articles

Executive perspectives: Briggs Morrison

Briggs Morrison of AstraZeneca shares his views on emerging biological therapies, personalized medicine and clinical trial transparency. Pharma R&D is being shaped by many issues – biological therapies, personalized medicine and clinical...

Articles

A new paradigm for drug discovery: part two – tapping into o...

In part two of four, Dr Kevin Lustig and Dr Maria Thompson discuss the two barriers to any science or pharma project: facilities and funds. Drug discovery and life science research are changing before our very eyes. In part one of this series, we discussed how the mass of...

Articles

Patient perspectives: Katherine Leon

Katherine Leon suffered a rare and under-researched condition, Spontaneous Coronary Artery Dissection (SCAD). With her help the Mayo Clinic set up a clinical trial in this area. Katherine shares her story here. Heart attack symptoms can be pretty scary, but when no cause is attributed to them it can be very worrying. This is what...

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Sales & Marketing

Female pharmacist with male patient in pharmacy

Your DTP programme has five vendors and no spine

Over the past few years, many pharma brands set out to build a direct-to-patient (DTP) channel. The website went live. A telehealth partner was selected. Pharmacy logistics were set up.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital